Events

Mdma events

MDMA’s four flagship events – our FDA Forum, Annual Meeting, Executive Forum, and Reimbursement & Health Policy Conference – have become must-attend conferences for medical technology executives and are open to members and non-members alike. Whether your goal is to advocate for specific policies, learn the latest developments from industry leaders, or network with fellow MedTech professionals, an upcoming MDMA event will deliver value to you and your colleagues. MDMA members also receive opportunities to attend member-only meetings, webinars, roundtables, and more.

featured events

Two men sitting next to each other, speaking at an event
November 13-14, 2024, Washington, DC

MDMA 2024 Reimbursement & Health Policy Conference

Join reimbursement and market access leaders from across the industry for this must-attend two day event held in Washington, DC
See more
March 12-13, 2025, Palo Alto, CA

MDMA 2025 FDA Forum

Save the date for MDMA's popular FDA Forum which will be held in Palo Alto, CA March 12-13, 2025.

MDMA Partner events

There are no MDMA webinars scheduled at this time, but check back soon!

Past events

Close ups of the event booklets
September 20, 2024

MDMA's 2024 Medical Technology Executive Forum

MDMA's 2024 Executive Forum featured Acting CDRH Director, Dr. Michelle Tarver, CMS Principal Deputy Administrator & COO, Jon Blum, and several other leading industry voices. This conference focused on a range of policy, regulatory, legal, business, investment and security issues facing our industry.
Four people sitting in chairs on stage at an event
April 17, 2024

MDMA 2024 Annual Meeting

MDMA hosted nearly 200 medtech executives and innovators in DC for our Annual Meeting. Attendees heard from FDA Commissioner Dr. Califf, CDRH Director Shuren, CMS Acting CMO Dora Hughes, Senator Bill Cassidy (LA), Reps. Eshoo (CA), Trahan (MA), Joyce (PA), and many others from government and industry. Attendees also met with the offices of over 45 Members of Congress to discuss issues of importance to medtech innovators.